KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Equity Ratio: 2010-2024

Historic Equity Ratio for Pacira BioSciences (PCRX) over the last 15 years, with Dec 2024 value amounting to 0.50.

  • Pacira BioSciences' Equity Ratio rose 13.77% to 0.56 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56, marking a year-over-year increase of 13.77%. This contributed to the annual value of 0.50 for FY2024, which is 9.35% down from last year.
  • Per Pacira BioSciences' latest filing, its Equity Ratio stood at 0.50 for FY2024, which was down 9.35% from 0.55 recorded in FY2023.
  • Pacira BioSciences' Equity Ratio's 5-year high stood at 0.55 during FY2023, with a 5-year trough of 0.35 in FY2021.
  • In the last 3 years, Pacira BioSciences' Equity Ratio had a median value of 0.50 in 2024 and averaged 0.50.
  • Its Equity Ratio has fluctuated over the past 5 years, first dropped by 27.62% in 2021, then surged by 30.98% in 2022.
  • Over the past 5 years, Pacira BioSciences' Equity Ratio (Yearly) stood at 0.49 in 2020, then declined by 27.62% to 0.35 in 2021, then skyrocketed by 30.98% to 0.46 in 2022, then climbed by 19.89% to 0.55 in 2023, then fell by 9.35% to 0.50 in 2024.